Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Discontinues TAK-128 Clinical Program For Peripheral Diabetic Neuropathy

Nov 02 2006

• By Jessica Merrill

Related Content

Takeda’s Combo Duetact Will Launch Later This Year For Type 2 Diabetes

Jul 31 2006

Takeda/BioNumerik’s Tavocept Phase III Data Did Not Meet Primary Endpoints

Aug 01 2006

Takeda Drops Phase II Diabetes Drug

Sep 08 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window